What is the Nuvalent Inc (NUVL) price today?

The price of Nuvalent Inc (NUVL) today is $104.5. This value reflects the latest market rate available on Pluang. Check the asset page for additional details such as 24-hour change, market trends, and trading volume.

What are the trading hours of US Stocks?

US stocks trading hours: Monday - Friday (Except for US public holidays) Time: 21.30 - 04.00 WIB 20.30 - 03.00 WIB (Daylight Savings Time*) *The next Daylight Savings is scheduled to begin on March 13, 2022 and ends on November 6, 2022. You can place limit orders outside of the trading hours, but it can only be executed during trading hours. For illustration, a stock is currently trading at $10 per share, but you only want to pay $7 per share at most. Let’s say you set your limit price to $7 at 18.00. Your order will be executed when the market is open at 21.30 if the stock drops from $10 to $7 or lower. Similarly, if the stock price doesn’t drop to $7, your order won’t be executed.

Do I get a dividend from investing in US Stocks?

Yes, you are eligible to receive dividend payment if and when the company pays them on one condition: minimum net dividend paid is at least $0.01. Net dividend is gross dividend subtracted by 15% withholding tax.

What is the fee for each transaction?

Pluang charges a fixed transaction fee of 0.30% for regular users and 0.20% for Pluang Plus members, including VAT to cover the exchange fees and operational costs.

Trade on Pluang

One platform for all markets

Download

Investment

Features

Fees Safety

Academy

Pluang+

Home/Explore/US Market Price/Stocks/NUVL

Buy & Sell Nuvalent Inc (NUVL) – Nuvalent Inc Price Today

Overview Financials Technicals Analysis Corp Action About

24H

YTD

Aura AI Summary

Nuvalent (NUVL) is a clinical-stage biopharmaceutical company trading at $108.05, down 0.73% on the day. The stock shows strong analyst support with 14 unanimous buy ratings and a consensus price target of $134, representing 24% upside. Recent catalysts include NDA submissions for lead oncology drugs neladalkib and zidesamtinib, with key FDA review milestones approaching in 2026. The company reported negative profitability metrics but maintains substantial cash reserves of $1.4 billion to fund commercialization efforts.

Investment outlook hinges on successful FDA approvals and commercial execution of pipeline drugs. While analyst consensus is strongly bullish, risks include clinical trial outcomes, regulatory hurdles, and competitive pressures in the oncology space. The current valuation at 6.58x book value reflects expectations for future revenue growth from pipeline assets rather than current financial performance.

Read full analysis

Key Stats

Market Cap
$8.22B
Sector
Technology
3M Drawdown
-11.57%
Enterprise Value
$6.84B
Dividend Yield
-
Trading Activity
100% Buy | 0% Sell
Typical Hold Time
1 days

$104.5

52W Low: $66.72

07 May 2025

52W High: $111.99

22 Jan 2026

Nuvalent Inc (NUVL) is currently valued at a market capitalization of $8.22B, with an enterprise value of $6.84B. Over the past 52 weeks, Nuvalent Inc has traded between a low of $66.72 and a high of $111.99, highlighting its annual price range. Over the past three months, Nuvalent Inc has recorded a drawdown of -11.57%, reflecting recent price volatility. On average, investors hold Nuvalent Inc for approximately 1 days, indicating typical investor behavior on the platform.

About Nuvalent Inc

Nuvalent, Inc. is a clinical-stage oncology company focused on creating precisely targeted therapies for patients with cancers driven by specific gene mutations. The company leverages a deep understanding of structural biology and medicinal chemistry to design novel small-molecule kinase inhibitors to overcome resistance mechanisms in advanced solid tumors. Nuvalent is committed to developing its pipeline of candidates to address high unmet needs in the treatment of various cancers.

Technical Indicators

Overall Summary

Bearish (19)Neutral (0)Bullish (8)

News

Benzinga2 year ago

Nuvalent Stock Jumps On ESMO Data Presentation, Seeks To Raise $350M Via Equity

Zacks Investment2 year ago

Why Earnings Season Could Be Great for Nuvalent (NUVL)

The Motley Fool3 year ago

Why Nuvalent Stock Tanked on Tuesday

Benzinga3 year ago

Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Are Secretly Monitoring But Not Talking About Yet

The Motley Fool3 year ago

Why Nuvalent Stock Skyrocketed 35% This Week

People also bought

US Stocks risk is managed by PT PG Berjangka which has a license from the Badan Pengawas Perdagangan Berjangka Komoditi (BAPPEBTI), and your investment is guaranteed by the Jakarta Futures Exchange (JFX) and the Indonesian Clearing House (KBI). Read our product’s Terms and Conditions. View Terms and Conditions

Key Stats

Market Cap
$8.22B
Sector
Technology
3M Drawdown
-11.57%
Enterprise Value
$6.84B
Dividend Yield
-
Trading Activity
100% Buy | 0% Sell
Typical Hold Time
1 days

$104.5

52W Low: $66.72

07 May 2025

52W High: $111.99

22 Jan 2026

Let’s invest in this asset by signing up or download!

Buy & Sell Nuvalent Inc (NUVL) – Nuvalent Inc Price Today

Aura AI Summary

Key Stats

About Nuvalent Inc

People also bought

Key Stats

Invest

Features

Fees

Learn

Investment Clubs (Coming Soon)

Support

iOS App Store

Google Play Store